Metabolic & GLP-1 Analogues
Triple Receptor Agonist LY-3437943
Scientific Profile
Retatrutide is a long-acting synthetic peptide agonist of glucagon, GIP, and GLP-1 receptors. In vitro studies demonstrate high affinity binding to all three receptors with balanced activation. Animal models show significant effects on glucose metabolism, energy expenditure, and body weight through multiple mechanisms.
The peptide incorporates fatty acid acylation for albumin binding, extending its half-life in biological systems. Research indicates synergistic effects from triple receptor activation.
This compendium provides objective scientific information on research peptides based solely on published literature. All descriptions are limited to biochemical properties and mechanisms observed in in-vitro or animal studies, with no implications regarding human efficacy or therapeutic applications.